Canada Vascular Access Devices Market Assessment, By Product Type [Central Vascular Access Device, Peripheral Vascular Access Device, Accessories], By Application [Drug Administration, Fluid and Nutrition Administration, Blood Transfusion, Diagnostics], By End-user [Hospitals, Clinics, Ambulatory Surgical Centers, Others], By Region, Opportunities and Forecast, 2018-2032F

Canada vascular access devices market is projected to witness a CAGR of 6.03% during the forecast period 2025-2032, growing from USD 234.62 million in 2024 to USD 375.28 million in 2032. The rising number of hospitalizations requiring vascular access, a shift toward minimally invasive procedures for better patient outcomes, and innovations like antimicrobial-coated catheters. Increasing investment in Canadian healthcare infrastructure is also supporting rapid adoption. Moreover, heightened awareness around catheter-associated complications is pushing demand for safer and more efficient vascular access devices.

Report Attributes	Details
Base Year	2024
Forecast Period	2025-2032F
Historical Period	2018-2023
Projected Growth Rate	CAGR of 6.03% between 2025 and 2032
Revenue Forecast in 2032	USD 375.28 million

For instance, Teleflex Incorporated, a leading international supplier of medical technology, announced the introduction of two innovative devices in Canada that will improve PICC insertion procedures and lower the risk of problems. Vascular Access specialists can now implant PICCs more effectively and consistently due to the next-generation ArrowTM VPS RhythmTM DLX Device with NaviCurveTM Stylet.

Rising Incidence of Chronic Diseases Driving Demand for Vascular Access Devices

The increasing burden of chronic illnesses such as cancer, kidney disorders, and cardiovascular diseases in Canada is significantly contributing to the growing demand for vascular access devices. These conditions often require long-term treatment involving regular drug delivery, dialysis, chemotherapy, or blood transfusion procedures that rely heavily on efficient vascular access. The aging population in Canada further intensifies this need, as elderly individuals are more susceptible to such chronic conditions and typically require frequent hospital visits or home-based care supported by catheters or ports. Moreover, the Canadian government and healthcare authorities are actively promoting early diagnosis and long-term management of chronic diseases, indirectly accelerating the adoption of advanced vascular access solutions. This trend is prompting hospitals and clinics nationwide to invest in more reliable, minimally invasive, and patient-friendly devices that enhance care quality, reduce hospital stays, and prevent complications like infections or device failures. For example, according to a 2024 report by the Canadian Cancer Society, nearly 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime, and 1 in 4 will die from the disease.

Technological Advancements in Vascular Access Devices Improve Patient Safety and Outcomes

Rapid innovation in vascular access devices is fueling the growth of this market in Canada. Technological developments like antimicrobial coatings, pressure-activated valves, and ultrasound-guided catheter placements enhance device safety and performance, reducing complications such as infections and thrombosis. Additionally, the emergence of implantable ports and peripherally inserted central catheters (PICCs) designed for long-term use is improving patient outcomes, particularly in oncology and chronic care. Canadian healthcare providers increasingly seek devices that offer real-time monitoring, enhanced sterility, and ease of insertion, resulting in a strong demand for technologically advanced systems. Furthermore, Canadian regulatory authorities, including Health Canada, are streamlining the approval process for innovative vascular devices, facilitating quicker market access for global manufacturers. These advancements are improving clinical efficiency and ensuring better patient satisfaction and cost-effectiveness for hospitals and healthcare systems. Moreover, in November 2023, BD Canada, Ltd. (Becton, Dickinson and Company (BD)) introduced its Nexiva Closed IV Catheter System with advanced stabilization and blood control features to reduce complications and improve safety.

Peripheral Vascular Access Devices Hold a Significant Market Share

The rising number of surgeries, hospital admissions, and outpatient procedures in Canada directly boosts the need for vascular access devices. Hospitals, ambulatory surgical centers, and clinics increasingly rely on peripheral and central venous catheters for fluid administration, drug delivery, and anesthesia during pre- and post-operative care. With Canada’s expanding healthcare infrastructure and the growing demand for elective and emergency surgeries, especially in orthopedics, cardiology, and oncology, vascular access devices are becoming more prevalent. Furthermore, the post-pandemic resumption of delayed surgeries has created a surge in demand for access devices across various healthcare facilities. Public and private investments in upgrading hospital facilities and increasing procedural throughput also encourage the procurement of high-performance vascular access systems to meet rising patient volumes efficiently and safely. According to the Canadian Institute for Health Information (CIHI), there were over 1.2 million surgical procedures performed in Canada during 2023, showing a strong rebound from previous years.

Download Free Sample Report

Future Market Scenario (2025-2032F)

The Canada vascular access devices market is poised for steady expansion in the coming years due to rising incidences of chronic diseases such as cancer and renal disorders that require long-term IV treatments. The increasing elderly population, catheter safety and infection prevention, advancements and expanding surgical procedures are expected to boost market demand significantly. Ongoing innovation and government support for healthcare modernization will accelerate growth across Canadian provinces.

Report Scope

“Vascular Access Devices Market Assessment, Opportunities and Forecast, 2018-2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of Canada vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2025 and 2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Segments Covered	Product Type, Application, End-user
Regions Covered	Atlantic, Central, Prairie, West Coast, and North
Key Companies Profile	BD Canada, Ltd., Teleflex Medical Canada Inc., Nipro Canada Corporation, ICU Medical Canada, Inc., AngioDynamics, Inc., Medtronic Canada ULC, B. Braun Canada Ltd., Terumo Medical Canada Inc., Cook Medical Inc., McArthur Medical Sales Inc.
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, the Canada vascular access devices market has been segmented into the following categories: 

• By Product Type
  • Central Vascular Access Device
  • Peripheral Vascular Access Device
  • Accessories
• By Application
  • Drug Administration
  • Fluid and Nutrition Administration
  • Blood Transfusion
  • Diagnostics
• By End-user
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • Atlantic
  • Central
  • Prairie
  • West Coast
  • North

Key Players Landscape and Outlook

The key players in the market are significantly investing in the development of vascular access devices and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

The Slip-Cath Beacon Tip hydrophilic selective catheter from Cook Medical is currently available in the United States and Canada. After working with doctors and clinicians to better satisfy their needs, the company is pleased to reintroduce this product, a hydrophilic angiographic catheter used in vascular and non-vascular operations, according to a news statement.

Key Players Operating in Canada Vascular Access Devices Market are:

• BD Canada, Ltd.
• Teleflex Medical Canada Inc.
• Nipro Canada Corporation
• ICU Medical Canada, Inc.
• AngioDynamics, Inc.
• Medtronic Canada ULC
• Braun Canada Ltd.
• Terumo Medical Canada Inc.
• Cook Medical Inc.
• McArthur Medical Sales Inc.

If you can't find what you're searching for or have any custom requirements for Canada vascular access devices market, you may approach our team at info@marketsandata.com